Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA 403 Forbidden error page is now displayed, replacing the usual study details with an access-denied message and site chrome. This indicates the page is not accessible at the moment, rather than a substantive update to the study information.SummaryDifference18%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedFunding information now includes a 2019 U.S. NIH Grant/Contract. The revision tag has been updated to v3.6.6, replacing the previous v3.6.5 reference.SummaryDifference0.0%

- Check55 days agoChange DetectedA new plain-language results summary for the DUO-E trial was added in Publications, with an updated publication date entry (2026-08-07) and revision tag v3.6.5, while older entries from 2026-05 and 2026-06 were removed.SummaryDifference0.1%

- Check69 days agoChange DetectedA page revision update from v3.6.3 to v3.6.4 indicates a maintenance-level change to the page's versioning, with the underlying study information remaining the same.SummaryDifference0.0%

- Check91 days agoChange DetectedThe revision tag was updated from v3.6.2 to v3.6.3. This appears to be a small deployment/build update and does not indicate changes to the page content or data presented.SummaryDifference0.0%

- Check98 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a newer release or update to the document.SummaryDifference0.0%

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.